NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq
Insider Sale
+$48,048
-13.52%
Shares
Shares Volume: 51,115 Shares
Average Share Price: $0.94
INSIDER
Zalevsky Jonathan
Chief R&D Officer (Officer)
reported on Dec 20 2024
traded on Dec 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 326,904 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $16,740.04 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $27,930.63 |
| COMPANY PREVIOUS TRADES |